title: TNFα antagonist therapy in axial spondyloarthritis: Can we do better?
authors.affiliation: Service de rhumatologie, CHRU de Besançon, université de Franche-Comté, boulevard Fleming, 25030 Besançon, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
authors.affiliation: Service de rhumatologie, hôpital Henri-Mondor Créteil, AP-HP, université Paris Est Créteil, EA EpiDermE, 94000 Créteil, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Claudepierre
authors.affiliation: Service de rhumatologie, CHU de Tours, université François-Rabelais, UMR CNRS 7292, 37000 Tours, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Goupille
authors.affiliation: Service de rhumatologie, CHU Sainte-Marguerite, AP-HM, Aix-Marseille université, 13000 Marseille, France.
authors.forename: Thao
authors.initials: T
authors.lastname: Pham
authors.affiliation: Service de rhumatologie, CHRU de Besançon, université de Franche-Comté, boulevard Fleming, 25030 Besançon, France. Electronic address: dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D025241:Spondylarthritis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha
keywords: Immunogenicity; Spondyloarthritis; TNFα antagonists; Treatment